Intrinsiqq
Protara Therapeutics Inc. logo

Protara Therapeutics Inc. Insider Trading

TARA

Compare
Last 12 months

Insiders sold $1.01M and bought nothing on the open market.

12% of the selling was scheduled in advance under 10b5-1 plans. CEO and President Jesse Shefferman sold 882K on Jun 29, 18% of their stake, outside a plan. The last open-market buy by an executive or director was in May 2025.

Net open-market
−$1.01M
0 buys · 3 sales
Under a 10b5-1 plan
12%
of the value sold
Insiders who bought / sold
0 / 2
executives and directors
Last open-market buy
May 2025
May 14, 2025

Get an email when TARA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jun 29No plan
    Jesse Shefferman
    CEO and President · sold 215,687 at $4.09
    882K
    18% of stake
  • Apr 810b5-1 plan
    Jacqueline Zummo
    Chief R&D Officer · sold 1,134 at $5.40
    6K
    1.2% of stake
  • Apr 110b5-1 plan
    Jacqueline Zummo
    Chief R&D Officer · sold 22,598 at $5.26
    119K
    19% of stake
  • May 14, 2025
    Richard S Levy
    Director · bought 20,000 at $3.19
    64K
    65% of stake
  • Mar 26, 202510b5-1 plan
    Jacqueline Zummo
    Chf Scientific Operations Off · sold 21,224 at $4.53
    96K
    18% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch TARA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with TARA

CompareIntrinsic value
HUMAHumacyte, Inc.
$0.45-17.97%0
DBVTDBV Technologies S.A.
$9.01-4.35%10
ALGSAligos Therapeutics Inc.
$1.22-2.40%10
DYAIDyadic International Inc.
$0.29-6.45%25
ATRAAtara Biotherapeutics, Inc.
$6.33-0.16%25
CRISCuris Inc.
$0.44-7.21%35
OTLKOutlook Therapeutics Inc.
$0.39-3.32%10
SABSSab Biotherapeutics Inc.
$2.81-3.44%19

Held by ETFs

TARA is in 3 US ETFs. The largest of them, with TARA's weight in each:

Spot a number that looks wrong? Check it in TARA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing TARA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.